“…For example, we have shown that rats readily selfadminister a b2-selective nicotinic receptor agonist (Liu et al, 2003). Conversely, nicotinic receptor antagonists have been found to block nicotine's effects on striatal dopamine release and turnover (Haikala and Ahtee, 1988;Nisell et al, 1994), nicotine-induced dopaminergic signaling and neuronal excitation (Hamada et al, 2004;Yin and French, 2000), the locomotor effects of nicotine (Clarke and Kumar, 1983;Curzon et al, 1996;Kuo et al, 1999), and nicotine-induced hypothermia (Haikala and Ahtee, 1988;Zarrindast et al, 2001). Similarly, nicotinic antagonists precipitate nicotine withdrawal (Adams and Cicero, 1998;Hildebrand et al, 1999;Watkins et al, 2000b) and decrease rates of nicotine self-administration (Corrigall and Coen, 1989;Donny et al, 1999;Shoaib et al, 1997;Watkins et al, 1999).…”